Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies

Nature Genetics

Volumn 19, Issue 1, 1998, Pages 56-59

  Botto, Marina ^a   Dell'Agnola, Chiara ^a   Bygrave, Anne E ^a   Thompson, E Mary ^c   Cook, H Terence ^b   Petry, Franz ^d   Loos, Michael ^d   Pandolfi, Pier Paolo ^e   Walport, Mark J ^a  

^a Rheumatology Section   (United Kingdom)

^b IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^c St Mary's Campus ^*  (United Kingdom)

^d Inst of Med Microbiol and Hygiene   (Germany)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1Q; HISTONE ANTIBODY; IMMUNOGLOBULIN G;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; COMPLEMENT DEFICIENCY; COMPLEMENT SYSTEM; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENE; GLOMERULONEPHRITIS; IMMUNOFLUORESCENCE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES, ANTINUCLEAR; AUTOANTIGENS; COMPLEMENT C1Q; CROSSES, GENETIC; GLOMERULONEPHRITIS; HOMOZYGOTE; KIDNEY GLOMERULUS; MICE; MICROSCOPY, ELECTRON;

EID: 0031778836     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/ng0598-56     Document Type: Article

References (20)

1. Walport, M.J. & Morgan, B.P. Complement deficiency and disease. Immunol. Today 12, 301-306 (1991).
2. Lachmann, P.J. & Walport, M.J. Deficiency of the effector mechanisms of the immune response and autoimmunity. in Ciba Foundation Symposium: Autoimmunity and Autoimmune diseases (ed. Whelan, J.) 129, 149-171 (Wiley, Chichester, 1987).
3. McAdam, R.A., Goundis, D. & Reid, K.M.B. A homozygous point mutation results in a stop codon in the C1q B-chain of a C1q-deficient individual. Immunogenetics 27, 259-264 (1988).
4. Bowness, P. et al. Hereditary C1q deficiency and systemic lupus erythematosus. Quart. J. Med. 87, 455-464 (1994).
5. Petry, F., Le, D.T., Kirschfink, M. & Loos, M. Nonsense and missense mutations in the structural genes of complement component C1q A and C chains are linked with two different types of complete selective C1q deficiencies. J. Immunol. 155, 4734-4738 (1995).
6. Slingsby, J.H. et al. Homozygous hereditary C1q deficiency and systemic lupus erythematosus. A new family and the molecular basis of C1q deficiency in three families. Arthritis Rheum. 39, 663-670 (1996).
7. Topaloglu, R. et al. Molecular basis of hereditary C1q deficiency associated with SLE and IgA nephropathy in a Turkish family. Kidney Int. 50, 635-642 (1996).
8. Petry, F., Izzet Berkel, A. & Loos, M. Multiple identification of a particular type of hereditary C1q deficiency in the Turkish population: review of the cases andadditional genetic and functional analysis. Human Genet. 100, 51-56 (1997).
9. Petry, F. et al. The mouse C1q genes are clustered on chromosome 4 and show conservation of gene organisation. Immunogenetics 43, 370-376 (1996).
10. Jevnikar, A.M., Slinger, G.G., Brennan, D.C., Xu, H.W. & Kelley, V.R. Dexamethasone prevents autoimmune nephritis and reduces renal expression of la but not costimulatory signals. Am. J. Pathol. 141, 743-751 (1992).
11. Baker, A.J. et al. Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J. Clin. Invest. 94, 2105-2116 (1994).
12. Korb, L.C. & Ahearn, J.M. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes. Complement deficiency and systemic lupus erythematosus revisited. J. Immunol. 158, 4525-4528 (1997).
13. LeFeber, W.P. et al. Ultraviolet light induces binding of antibodies to selected nuclear antigens on cultured human keratinocytes. J. Clin. Invest. 74, 1545-1551 (1984).
14. Golan, T.D., Elkon, K.B., Gharavi, A.E. & Krueger, J.G. Enhanced membrane binding of autoantibodies to cultured keratinocytes of systemic lupus erythematosus patients after ultraviolet B/ultraviolet A irradiation. J. Clin. Invest. 90, 1067-1076 (1992).
15. Casciola-Rosen, L.A., Anhalt, G. & Rosen, A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317-1330 (1994)
16. Rosen, A., Casciola-Rosen, L.A. & Ahearn, J. Novel packages of viral and selfantigens are generated during apoptosis. J. Exp. Med. 181. 1557-1561 (1995).
17. Casciola-Rosen, L.A., Rosen, A., Petri, M. & Schlissel, M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc. Natl. Acad. Sci. USA 93, 1624-1629 (1996).
18. Trinder, P., Faust, D., Petry, F. & Loos, M. Modulation of mRNA expression and secretion of C1q in mouse macrophages by anti-inflammatory drugs and cAMP: evidence for the partial involvement of a pathway that includes cyclooxygenase, protaglandin E2 and adenylate cyclase. Immunol. 84, 638-644 (1995).
19. Andrews, B.S. & Theofilopoulos, A.N. A microassay for the determination of hemolytic complement activity in mouse serum. J. Immunol. Methods 22, 273-281 (1978).
20. Burlingame, R.W. & Rubin, R.L. Subnucleosome structures as substrates in enzyme-linked immunosorbent assays. J. Immunol. Methods 134, 187-199 (1990).